[Serological and epidemiological effects of Salk vaccination against poliomyelitis in Tyrol].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000906:Antibodies / Q000032:analysis; D001317:Austria; D002648:Child; D006367:HeLa Cells; D006801:Humans; D007106:Immune Sera; D007110:Immunity, Active; D008875:Middle Aged; D009500:Neutralization Tests; D011051:Poliomyelitis / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D011054:Poliovirus Vaccine, Inactivated; D014611:Vaccination
D000906:Antibodies; D007106:Immune Sera; D011054:Poliovirus Vaccine, Inactivated
Die serologischen und epidemiologischen Auswirkungen der Salkschen Impfung gegen Poliomyelitis in Tirol.